視網膜靜脈阻塞:全球臨床實驗檢討

本報告提供全球視網膜靜脈阻塞治療藥物臨床實驗相關調查，各地區臨床實驗數資料，實驗階段，實驗狀況，採用主題及各類型贊助企業的臨床實驗資料，中斷(暫時停止，廢止，停止)的實驗清單等資料，為您概述為以下內容。

目錄

• 表格一覽
• 圖表一覽
• 簡介
• 視網膜靜脈阻塞
• 報告指南
• 臨床實驗 , 各地區
• 臨床實驗 , 各國
• - 亞太地區對臨床實驗有所貢獻的主要5個國家
• - 歐洲對臨床實驗有所貢獻的主要5個國家
• 對臨床實驗有所貢獻的主要國家 - 北美
• 對臨床實驗有所貢獻的主要國家 - 中東及非洲
• 對臨床實驗有所貢獻的主要國家 - 中南美
• 臨床實驗 金磚四國 各國
• 臨床實驗 G7 各國
• 臨床實驗 - G7 各國 , 各臨床實驗狀態
• 臨床實驗 E7 各國
• 臨床實驗 - E7 各國 , 各臨床實驗狀態
• 各階段臨床實驗
• 進行中的臨床實驗 各階段
• 臨床實驗 , 各臨床實驗狀態
• 未完成的臨床實驗; 視網膜靜脈阻塞
• 每段時期的實驗人數
• 有力的贊助商
• 參加主要企業 - 視網膜靜脈阻塞 治療藥物的臨床實驗
• 潛力治療藥物比較
• 臨床實驗簡介
• 臨床實驗概要; 主要企業
• Allergan, Inc.
• 臨床實驗概要; Allergan, Inc.
• Genentech, Inc.
• 臨床實驗概要; Genentech, Inc.
• Regeneron Pharmaceuticals, Inc.
• 臨床實驗概要; Regeneron Pharmaceuticals, Inc.
• Okuvision GmbH
• 臨床實驗概要; Okuvision GmbH
• Mid Atlantic Retina
• 臨床實驗概要; Mid Atlantic Retina
• Aleris Helse AS
• 臨床實驗概要; Aleris Helse AS
• Retina Associates of Cleveland, Inc.
• 臨床實驗概要; Retina Associates of Cleveland, Inc.
• Alimera Sciences, Inc.
• 臨床實驗概要; Alimera Sciences, Inc.
• Fovea Pharmaceuticals SA
• 臨床實驗概要; Fovea Pharmaceuticals SA
• 三和化學研究所
• 臨床實驗概要; 三和化學研究所
• Bayer AG
• 臨床實驗概要; Bayer AG
• Novartis AG
• 臨床實驗概要; Novartis AG
• 參天製藥
• 臨床實驗概要; 參天製藥
• Eyetech Pharmaceuticals, Inc.
• 臨床實驗概要; Eyetech Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• 臨床實驗概要; F． Hoffmann-La Roche Ltd.
• 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
• 京都大學
• 臨床實驗概要; 京都大學
• Johns Hopkins University
• 臨床實驗概要; Johns Hopkins University
• Barnes Retina Institute
• 臨床實驗概要; Barnes Retina Institute
• University of Toronto
• 臨床實驗概要; University of Toronto
• Shaheed Beheshti Medical University
• 臨床實驗概要; Shaheed Beheshti Medical University
• Duke University
• 臨床實驗概要; Duke University
• Medical University of Vienna
• 臨床實驗概要; Medical University of Vienna
• Yonsei University
• 臨床實驗概要; Yonsei University
• St. Erik Eye Hospital
• 臨床實驗概要; St. Erik Eye Hospital
• 滋賀醫科大學
• 臨床實驗概要; 滋賀醫科大學
• California Retina Consultants
• 臨床實驗概要; California Retina Consultants
• Manhattan Eye Ear & Throat Hospital
• 臨床實驗概要; Manhattan Eye Ear & Throat Hospital
• 山形大學醫學系附屬醫院
• 臨床實驗概要; 山形大學醫學系附屬醫院
• Retina Macula Institute
• 臨床實驗概要; Retina Macula Institute
• Instituto Universitario de ;talmobiologia Aplicada
• 臨床實驗概要; Instituto Universitario de ;talmobiologia Aplicada
• Midwest Eye-Banks
• 臨床實驗概要; Midwest Eye-Banks
• Baqiyatallah Medical Sciences University
• 臨床實驗概要; Baqiyatallah Medical Sciences University
• Stavanger University Hospital
• 臨床實驗概要; Stavanger University Hospital
• Shiraz University of Medical Sciences
• 臨床實驗概要; Shiraz University of Medical Sciences
• University of Leipzig
• 臨床實驗概要; University of Leipzig
• Five 主要 臨床簡介

附錄

• 簡稱
• 定義
• 調查方法
• 二級研究
• 關於GlobalData
• 諮詢方式
• 免責聲明
• 資訊來源

表格一覽

• 視網膜靜脈阻塞 全球治療藥物市場, 臨床實驗 各地區
• 視網膜靜脈阻塞 全球治療藥物市場, 臨床實驗 , 各國排名
• 視網膜靜脈阻塞 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 亞太地區, 主要5個國家
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 歐洲, 主要5個國家
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 北美, 主要國家
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 中東及非洲, 主要國家
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 中南美, 主要國家
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 金磚四國 各國
• 視網膜靜脈阻塞 治療藥物的臨床實驗, G7 各國
• 視網膜靜脈阻塞 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
• 視網膜靜脈阻塞 治療藥物的臨床實驗, E7 各國
• 視網膜靜脈阻塞 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
• 視網膜靜脈阻塞 全球治療藥物市場, 各階段臨床實驗
• 視網膜靜脈阻塞 全球治療藥物市場, 進行中的臨床實驗 各階段
• 視網膜靜脈阻塞 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
• 視網膜靜脈阻塞 全球治療藥物市場, 暫時停止的臨床實驗
• 視網膜靜脈阻塞 全球治療藥物市場, 中止的臨床實驗
• 視網膜靜脈阻塞 全球治療藥物市場, 終止的臨床實驗
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 平均登計對象人數趨勢
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 主要的贊助商
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 主要企業 各階段
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Allergan, Inc.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Genentech, Inc.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Regeneron Pharmaceuticals, Inc.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Okuvision GmbH
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Mid Atlantic Retina
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Aleris Helse AS
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Retina Associates of Cleveland, Inc.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Alimera Sciences, Inc.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Fovea Pharmaceuticals SA
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-三和化學研究所
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Bayer AG
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Novartis AG
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-參天製藥
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Eyetech Pharmaceuticals, Inc.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-F． Hoffmann-La Roche Ltd.
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-京都大學
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Johns Hopkins University
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Barnes Retina Institute
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-University of Toronto
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Shaheed Beheshti Medical University
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Duke University
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Medical University of Vienna
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Yonsei University
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-St. Erik Eye Hospital
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-滋賀醫科大學
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-California Retina Consultants
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Manhattan Eye Ear & Throat Hospital
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-山形大學醫學系附屬醫院
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Retina Macula Institute
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Instituto Universitario de ;talmobiologia Aplicada
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Midwest Eye-Banks
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Baqiyatallah Medical Sciences University
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Stavanger University Hospital
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-Shiraz University of Medical Sciences
• 視網膜靜脈阻塞 全球治療藥物臨床實驗市場, 臨床實驗-University of Leipzig

圖表一覽

• 視網膜靜脈阻塞 全球治療藥物市場, 臨床實驗 各地區 (%)
• 視網膜靜脈阻塞 全球治療藥物市場, 臨床實驗 , 各國排名
• 視網膜靜脈阻塞 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
• 視網膜靜脈阻塞 (%)治療藥物的臨床實驗, 亞太地區, 主要5個國家
• 視網膜靜脈阻塞 (%)治療藥物的臨床實驗, 歐洲, 主要5個國家
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 北美, 主要國家 (%)
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 中東及非洲, 主要國家 (%)
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 中南美, 主要國家 (%)
• 視網膜靜脈阻塞 治療藥物的臨床實驗, 金磚四國 各國 (%)
• 視網膜靜脈阻塞 治療藥物的臨床實驗, G7 各國 (%)
• 視網膜靜脈阻塞 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
• 視網膜靜脈阻塞 治療藥物的臨床實驗, E7 各國 (%)
• 視網膜靜脈阻塞 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
• 視網膜靜脈阻塞 全球治療藥物市場, 各階段臨床實驗 (%)
• 視網膜靜脈阻塞 全球治療藥物市場, 進行中的臨床實驗 各階段
• 視網膜靜脈阻塞 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 平均登計對象人數趨勢
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 主要的贊助商
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 主要企業 各階段
• 視網膜靜脈阻塞 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
• GlobalData 調查方法

Abstract

Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013" provides data on the Retinal Vein Occlusion clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinal Vein Occlusion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinal Vein Occlusion. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

TOC

Table of Contents

Table of Contents 2

• List of Tables 4
• List of Figures 6
• Introduction 7
• Retinal Vein Occlusion 7
• Report Guidance 7
• Clinical Trials by Region 8
• Clinical Trials by Country 9
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
• Top Five Countries Contributing to Clinical Trials in Europe 12
• Top Countries Contributing to Clinical Trials in North America 13
• Top Countries Contributing to Clinical Trials in Middle East and Africa 14
• Top Countries Contributing to Clinical Trials in Central and South America 15
• Clinical Trials by BRIC Nations 16
• Clinical Trials by G7 Nations 17
• Clinical Trials in G7 Nations by Trial Status 18
• Clinical Trials by E7 Nations 19
• Clinical Trials in E7 Nations by Trial Status 20
• Clinical Trials by Phase 21
• In Progress Trials by Phase 22
• Clinical Trials by Trial Status 23
• Unaccomplished Trials of Retinal Vein Occlusion 24
• Subjects Recruited Over a Period of Time 27
• Prominent Sponsors 28
• Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials 30
• Prominent Drug Comparison 32
• Clinical Trial Profiles 33
• Clinical Trial Overview of Top Companies 33
• Allergan, Inc. 33
• Clinical Trial Overview of Allergan, Inc. 33
• Novartis AG 34
• Clinical Trial Overview of Novartis AG 34
• Genentech, Inc. 35
• Clinical Trial Overview of Genentech, Inc. 35
• Novartis Pharmaceuticals Corporation 36
• Clinical Trial Overview of Novartis Pharmaceuticals Corporation 36
• Regeneron Pharmaceuticals, Inc. 37
• Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 37
• Mid Atlantic Retina 38
• Clinical Trial Overview of Mid Atlantic Retina 38
• Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
• Clinical Trial Overview of Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
• Aleris Helse AS 40
• Clinical Trial Overview of Aleris Helse AS 40
• Opocrin S.p.A 41
• Clinical Trial Overview of Opocrin S.p.A 41
• Retina Associates of Cleveland, Inc. 42
• Clinical Trial Overview of Retina Associates of Cleveland, Inc. 42
• Icon Bioscience, Inc. 43
• Clinical Trial Overview of Icon Bioscience, Inc. 43
• The EMMES Corporation 44
• Clinical Trial Overview of The EMMES Corporation 44
• Alimera Sciences, Inc. 45
• Clinical Trial Overview of Alimera Sciences, Inc. 45
• ARCA biopharma, Inc. 46
• Clinical Trial Overview of ARCA biopharma, Inc. 46
• Fovea Pharmaceuticals SA 47
• Clinical Trial Overview of Fovea Pharmaceuticals SA 47
• Sanwa Kagaku Kenkyusho Co., Ltd. 48
• Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 48
• Bayer AG 49
• Clinical Trial Overview of Bayer AG 49
• Santen Pharmaceutical Co., Ltd. 50
• Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 50
• Eyetech Pharmaceuticals, Inc. 51
• Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 51
• Valeant Pharmaceuticals International, Inc. 52
• Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 52
• Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
• Shaheed Beheshti Medical University 53
• Clinical Trial Overview of Shaheed Beheshti Medical University 53
• Kyoto University 54
• Clinical Trial Overview of Kyoto University 54
• Johns Hopkins University 55
• Clinical Trial Overview of Johns Hopkins University 55
• University of Toronto 56
• Clinical Trial Overview of University of Toronto 56
• Barnes Retina Institute 57
• Clinical Trial Overview of Barnes Retina Institute 57
• S:t Eriks Ogonsjukhus AB 58
• Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 58
• Shiga University of Medical Science 59
• Clinical Trial Overview of Shiga University of Medical Science 59
• Duke University 60
• Clinical Trial Overview of Duke University 60
• Medical University of Vienna 61
• Clinical Trial Overview of Medical University of Vienna 61
• Ludwig-Maximilians-Universitat Munich 62
• Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 62
• California Retina Consultants 63
• Clinical Trial Overview of California Retina Consultants 63
• Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
• Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
• Manhattan Eye Ear & Throat Hospital 65
• Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 65
• Yamagata University Hospital 66
• Clinical Trial Overview of Yamagata University Hospital 66
• Keio University Hospital 67
• Clinical Trial Overview of Keio University Hospital 67
• Stavanger University Hospital 68
• Clinical Trial Overview of Stavanger University Hospital 68
• The University of Chicago 69
• Clinical Trial Overview of The University of Chicago 69
• Shiraz University of Medical Sciences 70
• Clinical Trial Overview of Shiraz University of Medical Sciences 70
• Hospital Universitario Ramon y Cajal 71
• Clinical Trial Overview of Hospital Universitario Ramon y Cajal 71
• The Medical University of Graz 72
• Clinical Trial Overview of The Medical University of Graz 72
• Five Key Clinical Profiles 73

Appendix 214

• Abbreviations 214
• Definitions 214
• Research Methodology 215
• Secondary Research 216
• About GlobalData 216
• Contact Us 216
• Disclaimer 216
• Source 217

List of Tables

List of Tables

• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
• Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
• Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
• Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
• Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
• Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
• Retinal Vein Occlusion Therapeutics Clinical Trials, BRIC Countries, 2013* 16
• Retinal Vein Occlusion Therapeutics Clinical Trials, G7 Countries, 2013* 17
• Retinal Vein Occlusion Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
• Retinal Vein Occlusion Therapeutics Clinical Trials, E7 Countries, 2013* 19
• Retinal Vein Occlusion Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
• Retinal Vein Occlusion Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
• Retinal Vein Occlusion Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
• Retinal Vein Occlusion Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 33
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 34
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2013* 35
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2013* 36
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2013* 37
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid Atlantic Retina, 2013* 38
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu Kanghong Pharmaceuticals Group Co., Ltd., 2013* 39
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Aleris Helse AS, 2013* 40
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Opocrin S.p.A, 2013* 41
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Associates of Cleveland, Inc., 2013* 42
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Icon Bioscience, Inc., 2013* 43
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The EMMES Corporation, 2013* 44
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Alimera Sciences, Inc., 2013* 45
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2013* 46
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Fovea Pharmaceuticals SA, 2013* 47
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanwa Kagaku Kenkyusho Co., Ltd., 2013* 48
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 49
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2013* 50
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2013* 51
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2013* 52
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaheed Beheshti Medical University, 2013* 53
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 54
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 55
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 56
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2013* 57
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2013* 58
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2013* 59
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 60
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 61
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2013* 62
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Retina Consultants, 2013* 63
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2013* 64
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2013* 65
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Yamagata University Hospital, 2013* 66
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University Hospital, 2013* 67
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Stavanger University Hospital, 2013* 68
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 69
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2013* 70
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Ramon y Cajal, 2013* 71
• Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 72

List of Figures

List of Figures

• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
• Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
• Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
• Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
• Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
• Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
• Retinal Vein Occlusion Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
• Retinal Vein Occlusion Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
• Retinal Vein Occlusion Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
• Retinal Vein Occlusion Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
• Retinal Vein Occlusion Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
• Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
• Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
• GlobalData Methodology 215